Join
Live feed
·
INSIDERFilingvia Quantisnow
Mirum Pharmaceuticals Inc. logo

CHIEF EXECUTIVE OFFICER Peetz Christopher converted options into 12,500 shares and sold $657,088 worth of shares (6,831 units at $96.19), increasing direct ownership by 3% to 169,402 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIRM (Mirum Pharmaceuticals Inc.) and more on Quantisnow.